Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

Vaccine - 11 May 2009

Liu Xueqiao, Broberg Eeva, Watanabe Daisuke, Dudek Timothy, Deluca Neal, Knipe David M

Abstract excerpt

The herpes simplex virus 1 (HSV-1) d106 mutant virus is a multiple immediate-early gene deletion mutant virus that has been effective as an AIDS vaccine vector in rhesus macaques (Kaur A, Sanford HB, Garry D, Lang S, Klumpp SA, Watanabe D, et al. Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus. Virology...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Chlorocebus aethiops
Share to env Gene Products, Human Immunodeficiency Virus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Engineering

Share to Genetic Vectors

Share to Genome, Viral

Share to Herpesvirus 1, Human

Share to Immunogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 19428888
DOI: 10.1016/j.vaccine.2009.03.003
PMCID: PMC2680798

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.PMID 19428888Read ↗

Novel vaccine vectors for HIV-1Semantic proximity Read ↗

A HSV1 mutant leads to an attenuated phenotype and induces immunity with a protective effect.Semantic proximity Read ↗

A Novel DNA Vaccine Technology Conveying Protection against a Lethal Herpes Simplex Viral Challenge in MiceSemantic proximity Read ↗

Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in MiceSemantic proximity Read ↗

Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2.Semantic proximity Read ↗

Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 gag GeneSemantic proximity Read ↗

Immunization against genital herpes with a vaccine virus that has defects in productive and latent infectionSemantic proximity Read ↗

Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.Semantic proximity Read ↗

Generation of CD8+T-Cell Responses by a Recombinant NonpathogenicMycobacterium smegmatisVaccine Vector Expressing Human Immunodeficiency Virus Type 1 EnvSemantic proximity Read ↗

Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs.Semantic proximity Read ↗

Development and characterization of a new single cycle vaccine vector in the simian immunodeficiency virus model system.Semantic proximity Read ↗

Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.